- Home
- AMBA vs PTGX Comparison
AMBA vs PTGX Comparison
Compare AMBA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBA
- PTGX
- Stock Information
- Founded
- AMBA 2004
- PTGX 2006
- Country
- AMBA United States
- PTGX United States
- Employees
- AMBA N/A
- PTGX N/A
- Industry
- AMBA Semiconductors
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- AMBA Technology
- PTGX Health Care
- Exchange
- AMBA Nasdaq
- PTGX Nasdaq
- Market Cap
- AMBA 3.3B
- PTGX 2.9B
- IPO Year
- AMBA N/A
- PTGX 2016
- Fundamental
- Price
- AMBA $52.64
- PTGX $47.47
- Analyst Decision
- AMBA Buy
- PTGX Strong Buy
- Analyst Count
- AMBA 12
- PTGX 8
- Target Price
- AMBA $80.83
- PTGX $66.50
- AVG Volume (30 Days)
- AMBA 856.7K
- PTGX 789.1K
- Earning Date
- AMBA 05-29-2025
- PTGX 05-06-2025
- Dividend Yield
- AMBA N/A
- PTGX N/A
- EPS Growth
- AMBA N/A
- PTGX N/A
- EPS
- AMBA N/A
- PTGX 0.86
- Revenue
- AMBA $316,264,000.00
- PTGX $207,801,000.00
- Revenue This Year
- AMBA $20.37
- PTGX N/A
- Revenue Next Year
- AMBA $11.56
- PTGX $50.30
- P/E Ratio
- AMBA N/A
- PTGX $55.04
- Revenue Growth
- AMBA 44.54
- PTGX N/A
- 52 Week Low
- AMBA $38.86
- PTGX $27.00
- 52 Week High
- AMBA $85.15
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- AMBA 39.68
- PTGX 58.60
- Support Level
- AMBA $60.88
- PTGX $45.43
- Resistance Level
- AMBA $63.64
- PTGX $46.80
- Average True Range (ATR)
- AMBA 2.56
- PTGX 1.54
- MACD
- AMBA -0.67
- PTGX 0.34
- Stochastic Oscillator
- AMBA 13.48
- PTGX 94.26
About AMBA Ambarella Inc.
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.